聚甲微球对简单玛林的种群药理动力学/药理动力学模型的影响
Paola A Cárdenas1, Izabel Almeida Alves2,3, Bibiana Verlindo De Araujo4
1Departamento de Farmacia, Universidad Nacional de Colombia, Bogotá, Colombia.
Journal of microencapsulation
|October 26, 2024
概括
在大鼠中,聚甲 (PCL) 微球增强了6 - 甲基 (6MC) 的吸收和抗炎作用. 这种药物输送系统改善了药理动力学和药理动力学概况,提高了脂性药物的治疗潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
- 药物输送系统 药物输送系统
背景情况:
- 脂性药物往往面临着差的药理动力学和有限的治疗疗效的挑战.
- 微球药物输送系统为克服这些局限性提供了一个有希望的方法.
- 聚乙烯 (PCL) 是一种可生物降解的聚合物,经常用于控制药物释放.
研究的目的:
- 评估PCL微球对6-甲基 (6MC) 的药理动力学和药理动力学的影响.
- 评估6MC在PCL微球中封装时的抗炎活性.
- 为封装6MC.开发人口药理动力学 (PopPK) 和人口药理动力学/药理动力学 (PopPK/PD) 模型.
主要方法:
- 用6MC装载的PCL微球是使用乳化-蒸发方法制备的.
- 特性包括粒子大小,泽塔潜力,药物负载和捕获效率.
- 评估了体外释放,Wistar大鼠体内的药理动力学,以及抗炎活性 (卡拉基南诱导的脚胀).
主要成果:
- 微球的直径为2.97.1微米,泽塔电位为-10至-15mV.
- 药物负载范围从0.24毫克/毫克,封装效率在45.5%至75.9%之间.
- 波普基基模型表明增强的吸收和分布,对封装6MC的抗炎功效增加.
结论:
- PCL微球显著改善了6MC的药理动力学和药理动力学概况.
- 在PCL微球中封装6MC增强了其治疗潜力.
- 这种方法对改善脂性药物的输送有希望.
相关概念视频
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
90
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
90
Compartment Models: Two-Compartment Model
5.3K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.3K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
One-Compartment Open Model for IV Bolus Administration: General Considerations
165
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
165
Pharmacokinetic Models: Overview
600
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
600


